SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001068800-08-000127
Filing Date
2008-03-26
Accepted
2008-03-25 17:36:48
Documents
15
Period of Report
2007-03-31

Document Format Files

Seq Description Document Type Size
1 kv10k.txt 10-K 800798
2 ex10px.txt EX-10.(X) 21603
3 ex10py.txt EX-10.(Y) 21340
4 ex10pz.txt EX-10.(Z) 21585
5 ex10paa.txt EX-10.(AA) 21580
6 ex10pbb.txt EX-10.(BB) 22166
7 ex10pcc.txt EX-10.(CC) 34171
8 ex10pdd.txt EX-10.(DD) 21154
9 ex10pee.txt EX-10.(EE) 70630
10 ex21.txt EX-21 435
11 ex23p1.txt EX-23.1 2730
12 ex31p1.txt EX-31.1 4750
13 ex31p2.txt EX-31.2 4720
14 ex32p1.txt EX-32.1 1683
15 ex32p2.txt EX-32.2 1684
  Complete submission text file 0001068800-08-000127.txt   1052570
Mailing Address 2503 S HANLEY RD ST LOUIS MO 63144
Business Address 2503 S HANLEY RD ST LOUIS MO 63144 3146456600
KV PHARMACEUTICAL CO /DE/ (Filer) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-09601 | Film No.: 08710264
SIC: 2834 Pharmaceutical Preparations